Pralidoxime

Back to search

Molecule Structure

Scientific Name

Pralidoxime

Description of the Drug

Pralidoxime is a cholinesterase reactivator used to treat organophosphate poisoning.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00733

Brand Name(s)

Not Available

Company Owner(s)

Meridian Medical Technologies Llc, Wyeth Ayerst Laboratories, Meridian Medical Technologies Inc, Us Army Medical Research Materiel Command, Baxter Healthcare Corp Anesthesia And Critical Care, Baxter Healthcare Corp Anesthesia Critical Care

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Acetylcholinesterase SINGLE PROTEIN ACTIVATOR CHEMBL220

Unichem Links

SureChEMBL SCHEMBL439968
Human Metabolome Database HMDB0014871
DrugBank DB00733
PubChem 135398747 135484646 4884
Mcule MCULE-9475708961
NMRShiftDB 20209502
LINCS LSM-5708
Nikkaji J232.003G
BindingDB 234367 50239371
EPA CompTox Dashboard DTXSID1044144
DrugCentral 2231
Brenda 66982
Guide to Pharmacology 4652 7597
rxnorm PROTOPAM PRALIDOXIME PRALIDOXIME CHLORIDE PRALIDOXIME MESYLATE PRALIDOXIME CATION PRALIDOXIME IODIDE DUODOTE
KEGG Ligand C07400
ChEBI 8354
ZINC ZINC000004577910